-
Microsoft, Biotech Examine Covid-19 Immune Response
A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections.
-
TB Vaccine Test on Covid-19 Expanding to Europe
A clinical trial testing a current tuberculosis vaccine among health care workers in Australia is expanding in that country and to two European countries.
-
Biotech Gains Antibody Discovery, Manufacturing Funds
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics.
-
A.I.-Aided Method Predicts Glaucoma Progression
Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma.
-
Infographic – U.S. Public Divided on Contact Tracking
A survey by the Washington Post and University of Maryland released this week indicates the proposed app is getting a lukewarm reception at best.
-
Stroke Found in More Young Adult Covid-19 Patients
An analysis of medical records shows individuals age 30 to 50 with Covid-19 infections are more likely to experience a stroke than their non-infected counterparts.
-
Trial Tests Blood Pressure Drug as Covid-19 Treatment
A common type of blood pressure drug will soon be tested in a clinical trial as a treatment for severe cases of Covid-19 infections.
-
NIH Opens Covid-19 Diagnostic Test Challenge
National Institutes of Health began a competition for new diagnostic tests that can better determine the extent of Covid-19 infections in the U.S.
-
Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.
-
Blood Test Detects Multiple Early Cancers
A clinical trial enrolling some 10,000 women demonstrates the feasibility of a routine blood test to screen for multiple types of cancer in their early stages.